Neuropace, Inc. (NASDAQ: NPCE) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT NEUROPACE, INC.

Neuropace, Inc. (NASDAQ: NPCE)
Listen to this Section


$14.15
+0.2500 ( +1.73% ) 46.2K

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.

Market Data


Open $14.15
Previous Close $13.90
Volume 46.2K
Market Cap $418.17M
Day Range $13.66 - $14.38
52 Week Range $5.45 - $18.15
Shares Outstanding 29.85M
Change % +1.73%
Net Change ▲ 0.2500
Insider Ownership 0.00%
Exchange NASDAQ
Sector Miscellaneous
Industry None
IPO Year 2021
Country United States
Under Writer IPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -35,548.00

Date Type Amount Purchased Purchaser
2024-06-11 Sale -17774.00 Andrade Lisa
2024-06-11 Sale -17774.00 Ryan Renee

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jan 08, 2025
8-k 8K-related 15 Jan 08, 2025
3 Insider transactions 2 Jan 08, 2025
10-q Quarterly Reports 64 Nov 12, 2024
8-k 8K-related 15 Nov 12, 2024
4 Insider transactions 1 Oct 28, 2024
4 Insider transactions 1 Oct 24, 2024
4 Insider transactions 1 Oct 22, 2024
4 Insider transactions 1 Oct 18, 2024
4 Insider transactions 1 Oct 03, 2024

Latest News


× Before browsing our site, please accept our cookies policy